CancerPPD

This page gives details of Query peptides and provides facility to browse the same in CancerPPD database. Please wait while data is being retrieved. For more information see HELP page.

ID	PMID	SEQUENCE	NAME	LENGTH	ACTIVITY
1350	18931881	ETFSDLWKLL	PNC-28	10	Cytotoxicity=80% µMo/ml
1434	21955251	GIIKKIIIKKIIIKKIIIKKI	Cationic Amphiphilic	21	IC₅₀ = 4 µM
1435	21955251	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	IC₅₀ = >60 µM
1436	21955251	GIIKKIIIKKI	Cationic Amphiphilic	11	IC₅₀ = >500 µM
1437	21955251	GIIKKIIIKKIIIKKI	Cationic Amphiphilic	16	IC₅₀ = 25 µM
1438	21955251	GIIKKIIIKKIIIKKIIIKKI	Cationic Amphiphilic	21	IC₅₀ = 10 µM
1665	15796184	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	55 % Cytotoxity at 40 µg/ml
1666	15796184	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	55 % Cytotoxity at 40 µg/ml
2855	22084165	KLlLKlLkkLLKlLKKK	Lytik	17	IC₅₀=37.1 µMol/L
2856	22084165	KLlLKlLkkLLKlLKKK	Lytik	17	IC₅₀=28.0 µMol/L
2862	22084165	KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK	IL-4RaÐlytic hybrid peptide	33	IC₅₀=6.8 µMol/L
2863	22084165	KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK	IL-4RaÐlytic hybrid peptide	33	IC₅₀=7.5 µMol/L
2912	21849092	KLlLKlLkkLLKlLKKK	Lytik	17	IC₅₀= 13.5 µM
2924	21849092	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	IC₅₀=6.4 µM
3170	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	24.2 % inhibition of cell proliferation at 1 nM
3171	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	37.8 % inhibition of cell proliferation at 10 nM
3172	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	48.2 % inhibition of cell proliferation at 100 nM
3173	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	59.6 % inhibition of cell proliferation at 1 µM
3174	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	84.5 % inhibition of cell proliferation at 10 µM
3186	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	ED₅₀ =0.210 µM
4200	15867360	HSHRDFQPVLHLVALNSPLSGGMRG	hP1	25	39% inhibition at 7 mg/kg/d
4201	15867360	MRGIRGADFQAFQQARAVGLAGTFR	hP2	25	19% inhibition at 7 mg/kg/d
4202	15867360	TFRAFLSSRLQDLYSIVRRADRAAV	hP3	25	No inhibition at 7 mg/kg/d
4203	15867360	AAVPIVNLKDELLFPSWEALFSGSE	hP4	25	No inhibition at 7 mg/kg/d
4204	15867360	GSEGPLKPGARIFSFDGKDVLRHPT	hP5	25	29% inhibition at 7 mg/kg/d
4205	15867360	HPTWPQKSVWHGSDPNGRRLTESY	hP6	24	No inhibition at 7 mg/kg/d
4206	15867360	ETWRTEAPSATGQASSLLGGRLLGQ	hP7	25	No inhibition at 7 mg/kg/d
4207	15867360	LGQSAASAHHAYIVLAIENSFMTASKKK	hP8	28	No inhibition at 7 mg/kg/d
4218	15887970	Not Available	Sansalv amide A	Not Available	EC₅₀=7.5 µM
4264	None	lKKllKKllKKl	DL6K6	12	LC₅₀>100 µM
4267	None	lKKllKKllKKl	DDA-DL6K6-22	12	LC₅₀<3.125 µM
4270	None	lKKllKKllKKl	MA-DL6K6-23	12	LC₅₀<3.125 µM
4273	None	lKKllKKllKKl	PA-DL6K6-24	12	LC₅₀=3.125 µM
4276	None	lRRllRRllRRl	DL6R6	12	LC₅₀>100 µM
4279	None	DDAlRRllRRllRRl	DDA-DL6R6-25	15	LC₅₀=3.125 µM
4338	None	YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK	EB-Lytic	32	IC₅₀= 12 µM
4339	None	YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK	EB-Lytic	32	IC₅₀= 12 µM
4344	None	YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK	EB(H2R)-lytic	32	IC₅₀= 6.6 µM
4345	None	YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK	EB(H2R)-lytic	32	IC₅₀= 7.4 µM
4347	None	NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL	Sema3A(aa363-377) -nLytic	32	IC₅₀= 12.5 µM
4348	None	NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL	Sema3A(aa363-377) -nLytic	32	IC₅₀= 10.6 µM
4350	None	NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL	Sema3A(aa363-377) -nLytic	32	IC₅₀= 7.9 µM
4351	None	GRVPYPRGGLLkLLKklLKKLlKL	Sema3A(aa371-377) -nLytic	24	IC₅₀= 14.7 µM
4352	None	GRVPYPRGGLLkLLKklLKKLlKL	Sema3A(aa371-377) -nLytic	24	IC₅₀= 9.2 µM
4354	None	GRVPYPRGGLLkLLKklLKKLlKL	Sema3A(aa371-377) -nLytic	24	IC₅₀= 8.0 µM

CancerPPD :Database of Anticancer peptides and Proteins

Browse Result page of CancerPPD